Argentarii LLC Makes New $753,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Argentarii LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 2,509 shares of the company’s stock, valued at approximately $753,000.

Several other hedge funds also recently bought and sold shares of the company. Whipplewood Advisors LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth about $31,000. Legacy Investment Solutions LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter worth about $39,000. Activest Wealth Management boosted its stake in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares in the last quarter. Capital Performance Advisors LLP bought a new stake in shares of HCA Healthcare during the 3rd quarter worth about $41,000. Finally, Pinnacle Bancorp Inc. boosted its stake in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 2.6 %

NYSE HCA opened at $330.11 on Friday. The stock has a fifty day moving average of $316.70 and a 200-day moving average of $347.49. The stock has a market capitalization of $81.27 billion, a P/E ratio of 15.03, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the company posted $5.90 earnings per share. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on HCA shares. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. Royal Bank of Canada decreased their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. Bank of America reduced their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Truist Financial reduced their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Morgan Stanley reduced their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.